Many countries in southern Africa have adult prevalence rates of >10% of HIV. In other parts of Africa most countries have a prevalence of ~1% or less. On other continents most countries have less than 1%, including the US with 0.3% adult prevalence. [1] For all the people wondering why this vaccine is being tested where it is, it's because just like we did for the covid vaccine, you split people up into placebo vs vaccine groups and then wait to see how many people get the virus from each group. If rates of HIV infection are as low as in the United States, you'd need to test the vaccine on ~100-1000x more people to see if it worked.
Non sequitur, but too interesting not to share: The estimated risk of acquiring HIV from a single sexual act is way lower than I realized until recently. Receptive vaginal sex with an infected individual is estimated to lead to infection only 8/10,000 times. Receptive anal sex is ~10-20 fold higher, 138/10,000. Sharing needles with an infected person is 63/10,000 [2]. That means you could have an ejaculates worth of HIV virions in your rectum, and be uninfected 49 times out of 50. (However, HIV infects immune cells, so it's way more likely to find an immune cell to infect if there are more in the area. That means infections or inflammation from other causes increase your risk of acquiring HIV compared to having no infection or inflammation. Similarly, way more target cells in blood, so if you have epithelial damage your risk goes up.)
[1] https://en.wikipedia.org/wiki/List_of_countries_by_HIV/AIDS_...
[2] https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html